U.S. FDA approves Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
FDA clears vessel-sealing device for Medtronic’s Hugo robot
Granite Point Mortgage Trust stock falls after dividend cut and loan resolution update
Key facts: Apple Inc. $109.4B rev; A20 Pro tops PCs; iPhone Duo
Apple Raised Stakes with its $2000-Priced Foldable. But Can it Be the New Growth Engine?
New chemical wipes out 95% of termites without harming humans
Scientists solve a 50-year mystery and discover a new human blood group
Super-simple interface replaces a touchscreen with PVC and printer toner
NASA Invites Media to SpaceX’s 35th Resupply Launch to Space Station
This deep-sea enzyme survives heat that destroys most proteins
Japan's first robot ambulance works the 9-1-1 lines for humanoids